Azzad Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Azzad Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,784	Closed	-$379K	–	353
2026 Q2	$379K	Buy	+4,784	New	+$360K	0.03%	322
2018 Q4	–	Sell	-8,451	Closed	-$436K	–	310
2018 Q3	$436K	Hold	8,451	–	–	0.12%	255
2018 Q2	$352K	Buy	8,451 +664	+9%	+$29.4K	0.1%	269
2018 Q1	$343K	Buy	7,787 +400	+5%	+$20.3K	0.1%	257
2017 Q4	$372K	Hold	7,387	–	–	0.12%	241
2017 Q3	$375K	Hold	7,387	–	–	0.13%	234
2017 Q2	$376K	Buy	+7,387	New	+$344K	0.13%	226

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Azzad Asset Management's IONS Position: Q3 2026 in Review

Azzad Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 4,784 shares — an estimated $379K sold.

Azzad Asset Management first reported a position in IONS in Q2 2017 and held it in 7 quarters. The position peaked at $436K in Q3 2018. 249 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

Azzad Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
Azzad Asset Management sold 4,784 Ionis Pharmaceuticals shares in Q3 2026, an estimated $379K.
Azzad Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 7 quarters.
Azzad Asset Management's Ionis Pharmaceuticals position peaked at $436K in Q3 2018.
249 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Azzad Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.